Glucarpidase

(Voraxaze®)

Voraxaze®

Drug updated on 11/9/2023

Dosage FormInjection (intravenous; 1,000 units/vial)
Drug ClassCarboxypeptidase
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of toxic plasma methotrexate concentrations (>1 micromole per liter) in patients with delayed methotrexate clearance due to impaired renal function.

Product Monograph / Prescribing Information

Document TitleYearSource
Voraxaze (glucarpidase) Prescribing Information.2019BTG International Inc., Brentwood, TN

Systematic Reviews / Meta-Analyses

Clinical Practice Guidelines